Hi Stzenit,
City of hope identified cs1 bisantrene & cs2 brenquinar as FTO inhibitors. We’ve only talked on this thread about cs1, since you don’t mind offering alternate views, I’d be interested in your thoughts on cs2 as a competitor to bisantrene...
Note - I too am a firm believer of RAC and am confident we’ll get acquired in the next couple of years.
Hi Stzenit,City of hope identified cs1 bisantrene & cs2...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
-0.015(1.15%) |
Mkt cap ! $213.9M | |||
| Open | High | Low | Value | Volume |
| $1.33 | $1.35 | $1.28 | $34.20K | 26.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 682 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 1824 | 1 |
View Market Depth
| Last trade - 16.10pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.31 |
Change
-0.015 ( 0.38 %) |
||||
| Open | High | Low | Volume | ||
| $1.32 | $1.35 | $1.28 | 9710 | ||
| Last updated 15.59pm 25/04/2024 ? | |||||
| RAC (ASX) Chart |